INTERACTION OF BETA-1H GLOBULIN WITH CELL-BOUND C3B - QUANTITATIVE-ANALYSIS OF BINDING AND INFLUENCE OF ALTERNATIVE PATHWAY COMPONENTS ON BINDING
INTERACTION OF BETA-1H GLOBULIN WITH CELL-BOUND C3B - QUANTITATIVE-ANALYSIS OF BINDING AND INFLUENCE OF ALTERNATIVE PATHWAY COMPONENTS ON BINDING
复制标题
DOI:
10.1084/jem.147.6.1792
复制
发表时间:
1978-01-01
影响因子:
15.3
通讯作者:
RUDDY, S
中科院分区:
文献类型:
--
作者:
CONRAD, DH;CARLO, JR;RUDDY, S
Purified .beta.1H globulin (.beta.1H) was shown to bind to C3b [b fragment of complement component 3] coated cells by immunofluorescent and radioactive tracer techniques. With EAC43 [erythrocyte, antibody, C43 complex], the amount of .beta.1H bound was directly proportional to the amount of C3 used to prepare the cells; EA, EAC14 and EAC14oxy2 bound very small amounts of .beta.1H. The C3b binding site on .beta.1H was labile in that not all of the purified 125I-.beta.1H was capable of binding to C3b, even when an excess of cell-bound C3b was present. Scatchard analysis of binding of .beta.1H to C3b-coated cells indicated an equilibrium constant of 109 L/M. Deviations from linearity were regularly found on Scatchard analyses. The .beta.1H binding sites exhibit negative cooperativity in that as more sites become occupied, it becomes more difficult to fill the remaining sites. The stoichiometry of the reaction between C3b and .beta.1H was examined using EAC14oxy23 prepared with 131I-C3 and .beta.1H labeled with 125I. Between 0.5-0.8 .beta.1H molecules were bound per C3b molecule. Alternative pathway components influenced the binding of 125I-.beta.1H to cell bound C3b. Both C3b and native C3 inhibited binding of labeled .beta.1H at an efficiency approximately 1/1,000 that of unlabeled .beta.1H. Factor B inhibited binding with 1/280 the efficiency of unlabeled .beta.1H. Properdin [P] caused a dose-dependent increase in the binding of .beta.1H; this enhancement was abrogated if B was also present in the reaction mixture. Scatchard analysis indicated that the enhancement of .beta.1H binding by P resulted in an increased number of available binding sites rather than an increase in the affinity of binding.